Congratulations! The College proudly announces that the “EPAC Suture Anchor System,” developed by Dean Chun-Li Lin’s research team, has officially received a Class II Medical Device License from the Ministry of Health and Welfare (TFDA, Ref. No. 008911) on September 22, 2026. This monumental milestone underscores the College’s exceptional achievements in innovative orthopedic medical device R&D and technology translation.
Suture anchors are widely used medical implants in orthopedics and sports medicine. They are primarily designed to reattach damaged soft tissues—such as tendons, ligaments, and labrums—back to the bone to promote tissue healing and restore joint function. They are extensively applied in rotator cuff repairs, as well as tendon and ligament reconstruction surgeries for knees, elbows, and ankles.
Innovative Expandable Design Enhances Anchor Fixation and Pull-out Resistance
The EPAC Suture Anchor System was specifically engineered to overcome the fixation challenges of conventional suture anchors in patients with compromised bone quality. Featuring an innovative expandable mechanism, the anchor expands internally post-implantation to increase mechanical interlock with bone tissue. This design maximizes pull-out strength and minimizes the risk of post-operative anchor loosening caused by physiological movement.
Obtaining this medical device license demonstrates not only the College of BMSE’s robust R&D strength in orthopedic implants, but also marks a vital milestone in translating innovative technologies into clinical application and commercialization. Moving forward, the College will continue to integrate clinical needs with cross-disciplinary technologies, deepen industry-academia collaboration, and advance the development and practical application of next-generation medical devices.
